Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, including adeno-associated virus (AAV) gene therapies, as well as related consulting activities, project management and regulatory support.
Microbiology Product Areas
Pharmaceutical
Adeno-associated virus (AAV)
Show all suppliersATMP - Advanced Therapeutic Medicinal Products
Show all suppliersCell and Gene Therapies
Show all suppliersContract Research Organization (CRO)
Show all suppliersGene and Cell Therapies
Show all suppliers
advertisement
advertisement
advertisement
advertisement
advertisement
LATEST MICROBIOLOGY NEWS
MICROBIOLOGY EVENTS
-
How Is VIDAS® KUBE™ Transforming Food Pathogen Detection?
-
Sampling and Microbial Testing of Water and Data Trending
-
European Microbiology Conference and Workshop 2025
-
Environmental Monitoring: Overcoming Challenges with Manual Plate Reading
-
Discussion of USP and FDA Accepted LAL Reagent for the Bacterial Endotoxin Tests of <85> or <86>
-
Future Labs Live 2025
-
Improve Your Productivity with Legionella pneumophila Rapid Testing
-
Pharmig’s 18th Annual Irish Conference
-
Driving Quality Goals Through Analytical Tools & Standardization
-
2025 Endotoxin Testing Summit
